Researchers seeking to improve treatment outcomes for women with recurrent endometrial cancer – the most commonly diagnosed gynecologic malignancy in the U.S., killing more than 8,000 women each year – have reported positive results through targeted therapy that uses a combination of the drugs everolimus and letrozole. Their findings have been reported in the Journal of Clinical Oncology.
A multidisciplinary group of Miller School of Medicine researchers has identified an important association between baseline inflammatory states in asymptomatic patients and early development of coronary artery disease. The results have been published in the Online First edition of Heart: British Medical Journal as “Association between Anti-Human Shock Protein-60 and Interleukin-2 (IL-2) with Coronary Artery Calcium Score.”
The University of Miami Miller School of Medicine has been selected as a member of the Pulmonary Fibrosis Foundation Care Center Network and Patient Registry, a designation that will significantly enhance the clinical care provided to patients at UHealth – University of Miami Health System.
The Third Annual DOCS Dean’s 5K Walk/Run attracted more than 100 participants and raised nearly $5,000. The event, organized by Miller School of Medicine students, raises awareness and funds for the Mitchell Wolfson Sr. Department of Community Service (DOCS) to help buy supplies and equipment.
Alberto Pugliese, M.D., head of the Immunogenetics Program at the Diabetes Research Institute at the University of Miami Miller School of Medicine, has accepted the JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award on behalf of the JDRF Network for Pancreatic Organ Donors with Diabetes (nPOD).